Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
Concomitant use of rivaroxaban with non-dihydropyridine calcium channel blockers (non-DHPs) might lead to an increase of systemic rivaroxaban exposure and anticoagulant effects in relation to the inhibition of metabolic enzymes and/or transporters by non-DHPs. This study was designed to evaluate the...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2019-03-01
|
| Schriftenreihe: | Pharmaceutics |
| Schlagworte: | |
| Online-Zugang: | http://www.mdpi.com/1999-4923/11/3/133 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|